Clinical Trial Update: A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This document reports results from a Phase 2 study of mavrilimumab in adults with moderate-to-severe rheumatoid arthritis. The trial status is completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Mavrilimumab (mavrilimumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-09-27